Monica Perez

Bellaterra, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Persistent neurological and behavioral alterations after SARS-CoV-2 infection in an optimized K18-hACE2 mouse model.

Persistent neurological and behavioral alterations after SARS-CoV-2 infection in an optimized K18-hACE2 mouse model.

Journal: Frontiers in microbiology
Published: May 02, 2026

Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination.

Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination.

Journal: Vaccines
Published: September 08, 2025

Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.

Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.

Journal: Frontiers in microbiology
Published: June 13, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Journal: mBio
Published: April 24, 2025

Automated pixel-based quantification of porcine circovirus 2 genome in formalin-fixed, paraffin-embedded tissues using in situ hybridisation.

Automated pixel-based quantification of porcine circovirus 2 genome in formalin-fixed, paraffin-embedded tissues using in situ hybridisation.

Journal: Frontiers in veterinary science
Published: April 11, 2025

An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters.

An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters.

Journal: Scientific reports
Published: January 28, 2025

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Journal: Communications biology
Published: January 15, 2025

A case report of porcine circovirus 3 (PCV3) reproductive disease in Iberian semi-outdoor reared sows.

A case report of porcine circovirus 3 (PCV3) reproductive disease in Iberian semi-outdoor reared sows.

Journal: Porcine health management
Published: September 30, 2024

Porcine nasal organoids to model interactions between the swine nasal microbiota and the host.

Porcine nasal organoids to model interactions between the swine nasal microbiota and the host.

Journal: Microbiome
Published: September 18, 2024

Retrospective investigation of porcine circoviruses in cases of porcine dermatitis and nephropathy syndrome.

Retrospective investigation of porcine circoviruses in cases of porcine dermatitis and nephropathy syndrome.

Journal: Veterinary research
Published: June 28, 2024

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Journal: Frontiers in immunology
Published: September 10, 2023

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.

Journal: NPJ vaccines
Published: August 14, 2023
Showing 1-12 of 43

Last Updated: 09/26/2026